Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer.

Mediators of inflammation·2019
Same author

Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models.

Minerva gastroenterologica e dietologica·2019
Same author

Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions.

Nutrients·2019
Same author

The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD.

Nutrients·2019
Same author

Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis.

Clinical nutrition (Edinburgh, Scotland)·2019
Same author

Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2019

Related Experiment Video

Updated: May 29, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

Celiac disease and myointimal proliferation: a possible correlation?

Giuseppe Merra1, Antonio Dal Lago, Davide Roccarina

  • 1Department of Internal Medicine, Catholic University of Sacred Heart, 'Agostino Gemelli' General Hospital, Rome, Italy.

Case Reports in Gastroenterology
|September 8, 2011
PubMed
Summary

Celiac disease (CD), an autoimmune disorder triggered by gluten, can manifest with unusual vascular issues like myointimal proliferation. This case highlights a potential link between CD and vascular abnormalities in young women.

Keywords:
AbsorptionAtheromasiaAutoimmuneGliadinThrombosis

More Related Videos

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta
07:32

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta

Published on: February 7, 2018

Development of a Murine Model for Femoral Artery Anastomotic Stenosis
05:42

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Published on: April 18, 2025

Related Experiment Videos

Last Updated: May 29, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta
07:32

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta

Published on: February 7, 2018

Development of a Murine Model for Femoral Artery Anastomotic Stenosis
05:42

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Published on: April 18, 2025

Area of Science:

  • Gastroenterology
  • Immunology
  • Vascular Medicine

Background:

  • Celiac disease (CD) is an autoimmune small bowel disorder triggered by gluten in genetically susceptible individuals.
  • CD commonly presents with malabsorption symptoms, but can also manifest with non-gastrointestinal or atypical symptoms.
  • Vascular complications, including thrombosis, have been anecdotally reported in association with celiac disease.

Observation:

  • This article details a case of a young woman diagnosed with celiac disease (CD).
  • The patient presented with myointimal proliferation, a rare vascular abnormality.
  • This clinical presentation prompted a review of potential associations between CD and vascular conditions.

Findings:

  • The case report describes a patient with celiac disease exhibiting myointimal proliferation.
  • Multiple instances of vessel thrombosis have been previously documented in patients with CD.
  • While a direct causal link remains unestablished, a correlation is suggested.

Implications:

  • The findings suggest that celiac disease may be associated with specific vascular abnormalities, such as myointimal proliferation and thrombosis.
  • Healthcare providers should consider celiac disease in the differential diagnosis of young women presenting with unexplained vascular issues.
  • Further research is warranted to elucidate the pathophysiological mechanisms underlying the association between celiac disease and vascular disease.